FeesSafety
Pluang+

PharmAla Biotech signs deal to supply MDMA for Danish PTSD trial, gaining global data license.

Market News
09 Nov 2026, 14:30 WIB
GlobeNewsWire
View Source
Bullish
PharmAla Biotech signs deal to supply MDMA for Danish PTSD trial, gaining global data license.

PharmAla Biotech has signed an agreement with Aalborg University Hospital to be the exclusive supplier of its LaNeo™ MDMA for a Danish clinical trial studying MDMA-assisted treatment for service-related PTSD. The MIRROR study will compare psychotherapy versus music-assisted relaxation alongside MDMA treatment. PharmAla will receive a perpetual, worldwide license to the study's anonymized data, which will support its regulatory and commercial efforts. This deal strengthens PharmAla's clinical supply presence in the EU and advances understanding of MDMA treatment protocols.

PharmAla Biotech's recent agreement with Aalborg University Hospital for MDMA-assisted PTSD treatment comes as 108 of 150 priced Health-sector US stocks on Pluang rose today. For readers following the health sector, here is Pluang's market snapshot as of Nov 09, 2026 18:41 WIB: Inovio Pharmaceuticals Inc (INO) gained 11.93% to USD 1.36 with a typical hold time of 41 days, Cassava Sciences Inc (FLNA) rose 6.01% to USD 0.48 with a 39-day hold, while LifeStance Health Group Inc (LFST) fell 5.66% to USD 12.99 with a 12-day hold.

More News

New combo therapy shows promise in tough metastatic breast cancer cases with high response rates

New combo therapy shows promise in tough metastatic breast cancer cases with high response rates

Marengo Therapeutics presented interim Phase 2 results from the STARt-002 trial combining invikafusp alfa, a selective T-cell agonist, with sacituzumab govitecan in metastatic triple-negative and HR-positive/HER2-negative breast cancer. The trial sho...

Company Fundamentals
Bullish
46 minutes ago
Deadlines set for lead plaintiff appointments in class action lawsuits against Ensign, Netcapital, and Webull.

Deadlines set for lead plaintiff appointments in class action lawsuits against Ensign, Netcapital, and Webull.

Holzer & Holzer, LLC announced deadlines for investors to seek lead plaintiff status in shareholder class action lawsuits against The Ensign Group, Netcapital Inc., and Webull Corporation. These lawsuits allege misleading statements and failure to di...

Bearish
46 minutes ago
Octave launches Attune Facilities, an AI-driven tool for managing complex multi-site operations efficiently.

Octave launches Attune Facilities, an AI-driven tool for managing complex multi-site operations efficiently.

Octave Intelligence plc has introduced Octave Attune Facilities, a cloud-based software solution designed to help organizations manage multiple sites with AI-powered tools. This platform integrates building, space, maintenance, and operational data t...

Market News
Bullish
46 minutes ago
ITT Inc. price target raised to $259 after strong Q3 with 44% revenue growth and 20% earnings rise.

ITT Inc. price target raised to $259 after strong Q3 with 44% revenue growth and 20% earnings rise.

ITT Inc. reported a strong third quarter with revenue up 44% to over $1.40 billion and adjusted earnings rising 20% to $2.26 per share, driven by the SPX FLOW acquisition and 8% organic growth. Orders surged 58%, supported by aerospace, defense, and ...

Analyst Insights
Bullish
1 hour ago
Credit Agricole Toulouse 31 reports weekly cooperative investment certificate buybacks from Nov 2-6, 2026.

Credit Agricole Toulouse 31 reports weekly cooperative investment certificate buybacks from Nov 2-6, 2026.

Credit Agricole Toulouse 31 disclosed its weekly transactions involving the buyback of its cooperative investment certificates (CCI) from November 2 to November 6, 2026. The bank repurchased varying volumes daily, with prices ranging around 98.82 to ...

Market News
Neutral
1 hour ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App